473 related articles for article (PubMed ID: 31939725)
1. Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder.
Petković B; Kesić S; Pešić V
Curr Pharm Des; 2020; 26(4):466-484. PubMed ID: 31939725
[TBL] [Abstract][Full Text] [Related]
2. A New Look at an Old Drug: Cumulative Effects of Low Ribavirin Doses in Amphetamine-Sensitized Rats.
Petković B; Kesić S; Ristić S; Pavković Ž; Podgorac J; Stojadinović G; Pešić V
Curr Pharm Des; 2020; 26(31):3884-3894. PubMed ID: 32213154
[TBL] [Abstract][Full Text] [Related]
3. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors.
Müller CP; Carey RJ; Huston JP; De Souza Silva MA
Prog Neurobiol; 2007 Feb; 81(3):133-78. PubMed ID: 17316955
[TBL] [Abstract][Full Text] [Related]
4. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation.
Schoffelmeer AN; De Vries TJ; Wardeh G; van de Ven HW; Vanderschuren LJ
J Neurosci; 2002 Apr; 22(8):3269-76. PubMed ID: 11943828
[TBL] [Abstract][Full Text] [Related]
5. Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors.
Chen JF; Beilstein M; Xu YH; Turner TJ; Moratalla R; Standaert DG; Aloyo VJ; Fink JS; Schwarzschild MA
Neuroscience; 2000; 97(1):195-204. PubMed ID: 10771351
[TBL] [Abstract][Full Text] [Related]
6. Structural plasticity of the brain to psychostimulant use.
Nyberg F
Neuropharmacology; 2014 Dec; 87():115-24. PubMed ID: 25018041
[TBL] [Abstract][Full Text] [Related]
7. Parallel roles for dopamine in pathological gambling and psychostimulant addiction.
Zack M; Poulos CX
Curr Drug Abuse Rev; 2009 Jan; 2(1):11-25. PubMed ID: 19630734
[TBL] [Abstract][Full Text] [Related]
8. The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
Shen MY; Perreault ML; Fan T; George SR
Pharmacol Biochem Behav; 2015 Jan; 128():33-40. PubMed ID: 25444866
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.
Lee TH; Szabo ST; Fowler JC; Mannelli P; Mangum OB; Beyer WF; Patkar A; Wetsel WC
Drug Alcohol Depend; 2012 Jul; 124(1-2):11-8. PubMed ID: 22356892
[TBL] [Abstract][Full Text] [Related]
10. Psychostimulants: Basic and Clinical Pharmacology.
McCreary AC; Müller CP; Filip M
Int Rev Neurobiol; 2015; 120():41-83. PubMed ID: 26070753
[TBL] [Abstract][Full Text] [Related]
11. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats.
Vanderschuren LJ; Schmidt ED; De Vries TJ; Van Moorsel CA; Tilders FJ; Schoffelmeer AN
J Neurosci; 1999 Nov; 19(21):9579-86. PubMed ID: 10531460
[TBL] [Abstract][Full Text] [Related]
12. Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
Gerlach M; Grünblatt E; Lange KW
Atten Defic Hyperact Disord; 2013 Jun; 5(2):71-81. PubMed ID: 23605387
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D₁-D₂ receptor heteromer regulates signaling cascades involved in addiction: potential relevance to adolescent drug susceptibility.
Perreault ML; O'Dowd BF; George SR
Dev Neurosci; 2014; 36(3-4):287-96. PubMed ID: 24820626
[TBL] [Abstract][Full Text] [Related]
14. Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.
Xi ZX; Gardner EL
Curr Drug Abuse Rev; 2008 Nov; 1(3):303-27. PubMed ID: 19430578
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.
Neisewander JL; Cheung TH; Pentkowski NS
Neuropharmacology; 2014 Jan; 76 Pt B(0 0):301-19. PubMed ID: 23973315
[TBL] [Abstract][Full Text] [Related]
16. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D4 receptors in psychostimulant addiction.
Di Ciano P; Grandy DK; Le Foll B
Adv Pharmacol; 2014; 69():301-21. PubMed ID: 24484981
[TBL] [Abstract][Full Text] [Related]
18. Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study.
Rafizadeh R; Frankow L; Mahmood H; Poonia S; Mathew N; Danilewitz M; Bousman CA; Honer WG; Schütz CG
J Psychopharmacol; 2023 Oct; 37(10):1040-1048. PubMed ID: 37539972
[TBL] [Abstract][Full Text] [Related]
19. The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity.
Pierce RC; Bari AA
Rev Neurosci; 2001; 12(2):95-110. PubMed ID: 11392459
[TBL] [Abstract][Full Text] [Related]
20. D1 and D2 dopamine and opiate receptors are involved in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine.
Díaz-Otañez CS; Capriles NR; Cancela LM
Pharmacol Biochem Behav; 1997 Sep; 58(1):9-14. PubMed ID: 9264063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
